epl oil acquired energy xxi 23 bln
copper drops lowest level nearly four years
new york march 12 reuters us stocks declined wednesday putting sp 500 track third straight decline recent record high concerns grew strength chinas economy
london copper seen proxy chinas economic health fell fourth day lowest level since july 2010 recent china data suggested economic slowdown countrys firstever bond default last week increased concerns financing deals use industrial metal collateral could unravel sp materials index fell 03 percent
investors also continue monitor geopolitical developments earnings season drawn close amid light economic calendar leaving catalyst push benchmark sp index higher recent record close friday
weve climbed far continue climb definitely going seesaw move said rick meckler president libertyview capital management jersey city new jersey
enough investors willing take profits continue bad global news start make sales certainly china big part ukraine situation really cleared way
ukraines government appealed western help tuesday stop moscow annexing crimea black sea peninsula overrun russian troops seemed fixed course could formalize rule moscow within days
eu member states agreed wording sanctions russia including travel restrictions asset freezes responsible violating sovereignty ukraine according draft document seen reuters
dow jones industrial average fell 3875 points 024 percent 163125 sp 500 lost 564 points 03 percent 186199 nasdaq composite dropped 10967 points 025 percent 4296221
epl oil gas inc jumped 298 percent 3778 company agreed acquired larger rival energy xxi ltd 23 billion including debt energy xxi shares lost 57 percent
express inc dropped 94 percent 1652 apparel retailer reported fourthquarter earnings forecast profit current quarter fell far short analyst expectations
oxigene inc surged 942 percent company said experimental drug zybrestat combined roches cancer drug avastin significantly slowed progression recurrent ovarian cancer better avastin alone midstage clinical trial
geron corp plunged 65 percent 154 company said us food drug administration ordered halt trials cancer drug imetelstat concerns potential liver damage
